Team:Freiburg/Highlights

From 2013.igem.org

(Difference between revisions)
 
(334 intermediate revisions not shown)
Line 5: Line 5:
<head>
<head>
-
<!--
 
-
<script src="http://cdn.jquerytools.org/1.2.7/full/jquery.tools.min.js"></script>
 
-
<script language="JavaScript">
 
-
;(function($){ // secure $ jQuery alias
 
-
/*******************************************************************************************/
 
-
// jquery.event.wheel.js - rev 1
 
-
// Copyright (c) 2008, Three Dub Media (http://threedubmedia.com)
 
-
// Liscensed under the MIT License (MIT-LICENSE.txt)
 
-
// http://www.opensource.org/licenses/mit-license.php
 
-
// Created: 2008-07-01 | Updated: 2008-07-14
 
-
/*******************************************************************************************/
 
-
// jquery method
+
<!-- ******************************************************************* -->
-
$.fn.wheel = function( fn ){
+
<!-- STYLESCHEET -->
-
return this[ fn ? "bind" : "trigger" ]( "wheel", fn );
+
<!-- ******************************************************************* -->
-
};
+
-
// special event config
 
-
$.event.special.wheel = {
 
-
setup: function(){
 
-
$.event.add( this, wheelEvents, wheelHandler, {} );
 
-
},
 
-
teardown: function(){
 
-
$.event.remove( this, wheelEvents, wheelHandler );
 
-
}
 
-
};
 
-
// events to bind ( browser sniffed... )
+
<style>
-
var wheelEvents = !$.browser.mozilla ? "mousewheel" : // IE, opera, safari
+
-
"DOMMouseScroll"+( $.browser.version<"1.9" ? " mousemove" : "" ); // firefox
+
-
// shared event handler
+
p{color:white;}
-
function wheelHandler( event ){  
+
-
switch ( event.type ){
+
-
case "mousemove": // FF2 has incorrect event positions
+
-
return $.extend( event.data, { // store the correct properties
+
-
clientX: event.clientX, clientY: event.clientY,
+
-
pageX: event.pageX, pageY: event.pageY
+
-
});
+
-
case "DOMMouseScroll": // firefox
+
-
$.extend( event, event.data ); // fix event properties in FF2
+
-
event.delta = -event.detail/3; // normalize delta
+
-
break;
+
-
case "mousewheel": // IE, opera, safari
+
-
event.delta = event.wheelDelta/120; // normalize delta
+
-
if ( $.browser.opera ) event.delta *= -1; // normalize delta
+
-
break;
+
-
}
+
-
event.type = "wheel"; // hijack the event
+
-
return $.event.handle.call( this, event, event.delta );
+
-
};
+
-
+
-
/*******************************************************************************************/
+
-
})(jQuery); // confine scope
+
-
</script>
+
-
<script src=http://jqueryjs.googlecode.com/files/jquery-1.2.6.min.js></script>
 
-
<script src=http://threedubmedia.googlecode.com/files/jquery.event.wheel-1.0.js></script>
 
-
 
-
<script language="JavaScript">
 
-
$(document).ready(function() {
 
-
var z = 1;
 
-
$('body,html').bind('wheel', function(event) {
 
-
          var i = event.delta;
 
-
if (z==1){
 
-
          if(i<0){
 
-
                window.scrollTo(0,275); z++; return false;
 
-
                }
 
-
            else { window.scrollTo(0,0);}return false;
 
-
} else if(z==2){
 
-
          if(i<0){
 
-
                window.scrollTo(0,775); z++;return false;
 
-
                }
 
-
          else if (i>0) { window.scrollTo(0,275);z--;}return false;
 
-
} else if (z==3){
 
-
              if(i<0){
 
-
                window.scrollTo(0,1375); z++; return false;
 
-
                }
 
-
              else if (i>0) { window.scrollTo(0,775);z--;return false;}
 
-
} else if (z==4){
 
-
              if(i<0){
 
-
                window.scrollTo(0,1950); z++; return false;
 
-
                }
 
-
              else if (i>0) { window.scrollTo(0,1375);z--;return false;}
 
-
} else if (z==5){
 
-
              if(i<0){
 
-
                window.scrollTo(0,2550); z++;return false;
 
-
                }
 
-
              else if (i>0) { window.scrollTo(0,1950);z--;return false;}
 
-
} else if (z==6){
 
-
              if(i<0){
 
-
                window.scrollTo(0,3100); z++; return false;
 
-
                }
 
-
              else if (i>0) { window.scrollTo(0,2550);z--;return false;}
 
-
} else if (z==7){
 
-
              if(i<0){
 
-
                window.scrollTo(0,3680); z++; return false;
 
-
                }
 
-
              else if (i>0) { window.scrollTo(0,3100);z--;return false;}
 
-
} else if (z==8){
 
-
              if(i<0){
 
-
                  return false;
 
-
                }
 
-
              else if (i>0) { window.scrollTo(0,3680);z--; return false;}
 
-
}
 
-
 
-
});
 
-
});
 
-
 
-
</script>
 
-
 
-
-->
 
-
<style>
 
#1{
#1{
Line 132: Line 29:
font-size: 50px;
font-size: 50px;
font-weight: bold;
font-weight: bold;
 +
}
}
Line 149: Line 47:
float:left;
float:left;
text-align:justify;
text-align:justify;
-
width:500px;
+
width:450px;
 +
margin-left;20px;
}
}
Line 156: Line 55:
font-size:18px;
font-size:18px;
text-align:justify;
text-align:justify;
-
width:500px;
+
width:600px;
 +
padding-left:5px;
}
}
Line 164: Line 64:
}
}
-
#tabelle tr td{
 
-
border: none;
 
-
}
 
-
#tabelle tr{
 
-
border: none;
 
-
}
 
-
#tabelle{
 
-
border: none;
 
-
}
 
-
#trennlinie{
+
/*
-
width:1050px;
+
* jQuery FlexSlider v2.0
-
}
+
* http://www.woothemes.com/flexslider/
 +
*
 +
* Copyright 2012, Julia Voß
 +
* Free to use under the MIT license.
 +
* http://www.opensource.org/licenses/mit-license.php
 +
*/
 +
 +
/* Browser Resets */
 +
.flex-container a:active,
 +
.flexslider a:active,
 +
.flex-container a:focus,
 +
.flexslider a:focus  {outline: none;}
 +
.slides,
 +
.flex-control-nav,
 +
.flex-direction-nav {margin: 0; padding: 0; list-style: none;}  
-
#rahmen tr td{
+
/* FlexSlider Necessary Styles
-
border:none;
+
*********************************/
-
}
+
.flexslider {margin: 0; padding: 0;}
 +
.flexslider .slides > li {display: none; -webkit-backface-visibility: hidden;} /* Hide the slides before the JS is loaded. Avoids image jumping */
 +
.flexslider .slides img {display: block;}
 +
.flex-pauseplay span {text-transform: capitalize;}
-
#rahmen tr{
+
/* Clearfix for the .slides element */
-
border:none;
+
.slides:after {content: "."; display: block; clear: both; visibility: hidden; line-height: 0; height: 0;}
-
}
+
html[xmlns] .slides {display: block;}
 +
* html .slides {height: 1%;}
-
#rahmen{
+
/* No JavaScript Fallback */
-
border:none;
+
/* If you are not using another script, such as Modernizr, make sure you
-
}
+
* include js that eliminates this class on page load */
 +
.no-js .slides > li:first-child {display: block;}
-
b{
+
/* FlexSlider Default Theme
-
color: #ffcc00;
+
*********************************/
 +
.flexslider {
 +
background-color: transparent; border: 8px solid transparent; position: relative; -webkit-border-radius: 4px; -moz-border-radius: 4px; -o-border-radius: 4px; border-radius: 4px; box-shadow: 0 1px 4px rgba(0,0,0,.2); -webkit-box-shadow: 0 1px 4px rgba(0,0,0,.2); -moz-box-shadow: 0 1px 4px rgba(0,0,0,.2); -o-box-shadow: 0 1px 4px rgba(0,0,0,.2); zoom: 1;
}
}
 +
.flex-viewport {max-height: 2000px; -webkit-transition: all 1s ease; -moz-transition: all 1s ease; transition: all 1s ease;}
 +
.loading .flex-viewport {max-height: 300px;}
 +
.flexslider .slides {zoom: 1;}
-
#rahmen tr td{
+
.carousel li {margin-right: 5px}
-
height:500px !important;
+
-
}
+
-
</style>
+
-
</head>
+
-
<body>
 
-
<div id="content_main">
+
/* Direction Nav */
 +
.flex-direction-nav {*height: 0;}
 +
.flex-direction-nav a {
 +
width: 35px;
 +
height: 32px;
 +
margin: -20px 0 0;
 +
display: block;
 +
background: url(https://static.igem.org/mediawiki/2013/e/eb/Controls1.png) no-repeat 0 0;
 +
position: absolute;
 +
top: 50%;
 +
cursor: pointer;
 +
text-indent: -9999px;
 +
}
-
<table id="rahmen" style="margin-top:-200px;">
+
-
<tr>
+
.flex-direction-nav .flex-next {background-position: -35px 0; right: 0px; }
-
<td id="number1">
+
.flex-direction-nav .flex-prev {background-position: 0px 0; left: 0px;}
 +
.flex-direction-nav .flex-disabled {opacity: .3!important; filter:alpha(opacity=30); cursor: default;}
-
<p id="h1">
 
-
HIGHLIGHTS
 
-
</p>
 
-
<p id="preample" style="width:450px;">
+
/* Control Nav */
-
<p id="h4">In the last months we were able to...</p>
+
.flex-control-nav {
 +
    width: 100%;  
 +
    position: absolute;
 +
    bottom: 30px;
 +
    left: 58px;
 +
    text-align: center;
 +
}
-
<ul style="font-size:18px">
+
.flex-control-nav li {margin: 0 0 0 5px; display: inline-block; zoom: 1; *display: inline;}
 +
.flex-control-nav li:first-child {margin: 0;}
 +
.flex-control-nav li a {width: 13px; height: 13px; display: block; background: url() no-repeat 0 0; cursor: pointer; text-indent: -9999px;}
 +
.flex-control-nav li a:hover {background-position: 0 -13px;}
 +
.flex-control-nav li a.active {background-position: 0 -26px; cursor: default;}
-
    <li>...construct a catalytically inactive version of <b>Cas9</b> and thus generate a <b>DNA binding protein</b>.</li>
 
-
    <li>...combine this modified dCas9 with different transcriptional <b>effectors</b>.</li>
 
-
    <li>...express this system in various <b>mammalian</b> cell lines.</li>
 
-
    <li>...<b>control</b> mammalian gene expression via our modified CRISPR/Cas system.</li>
 
-
    <li>...regulate gene expression on <b>light stimulus</b>.</li>
 
-
    <li>...develop a method to assess the <b>DNA binding capacity</b> of our dCas9-fusion proteins.</li>
 
-
    <li>...make our dCas9 <b>accessible</b> to the whole iGEM community by mutating illegal iGEM restriction sites</b>.</li>
 
-
<li>...build an online tool that generates customized <b>manuals</b> for using our toolkit.
 
-
<br>
 
-
<br>
 
-
<p>In summary we can now offer a universally applicable <b>toolkit</b> for gene regulation.</p>
 
-
</ul>
 
-
</p>
+
.flexslider {
 +
    width:1000px;
 +
height:500px;
 +
margin-left:15px;
-
</td>
+
}
-
</tr>
+
 +
div.frontpage-slide {
 +
    height: 500px;
 +
    background-color: transparent;
 +
width:950px;
 +
margin-left:40px;
 +
}
-
<tr>
+
div.frontpage-slide img{
-
<td>
+
  width:480px;
 +
    float: left;
 +
margin-right:10px;
 +
          margin-left:5px;               
-
<a href="#trennlinie1"><img id="trennlinie" src="https://static.igem.org/mediawiki/2013/1/16/Trennlinie_freiburg_13.png"></a>
+
}
 +
div.slide-right-col {
 +
    color: black;
 +
    float: right;
 +
  width:550px;
 +
    font-size: 16px;
 +
 +
 
 +
    line-height: 1.5em;
 +
text-align:justify;
 +
background-color: transparent;
 +
}
 +
div.slide-heading {
 +
color: black;
 +
    font-size: 18px;
 +
    font-weight: bold;
 +
    margin-bottom: 20px;
 +
}
-
<!-- **************************************************************************************************************************************************
+
div.slide-right-col p a{
 +
color:white;
 +
}
 +
table{margin-left:-10px;}
-
KACHELN
+
</style>
-
************************************************************************************************************************************************** -->
+
<script src="https://ajax.googleapis.com/ajax/libs/jquery/1.6.2/jquery.min.js"></script>
 +
<script src="http://2012.igem-bielefeld.de/includes/wiki/flex/js/jquery.flexslider.js"></script>
 +
<script type="text/javascript" charset="utf-8">
 +
  $(window).load(function() {
 +
    $('.flexslider').flexslider({
 +
          animation: "slide",  // slide or fade
 +
slideshow:false,
 +
       
 +
          controlsContainer: ".flex-container" // the container that holds the flexslider
 +
    });
 +
  });
-
<table id="tabelle" align="right">
 
-
<tr>
 
-
<td>
 
-
<div id="left_column" style="margin-top: -30px; margin-right: -50px;">
 
-
<p id="headline">
 
-
6 opportunities to customize your experiments
 
-
</p>
 
-
<p>
 
-
We provide 3 different effectors, 2 methods and 1 effector controller that allows to effectively repress or activate genes - also on stimulus. Use our custom-tailored <a id="link" href="https://2013.igem.org/Team:Freiburg/Project/toolkit"> Manual Tool </a> to generate your individual manual. Best of all: It's all open source and in iGEM standard!
 
-
</p>
 
-
</div>
 
-
</td>
 
-
<td>
 
-
<div id="right_column">
 
-
<img id="main_images" src="https://static.igem.org/mediawiki/2013/0/08/Symbols_farbenfroh_freiburg_13.png" style="height:600px; margin-left:-10px; margin-top:30px;">
+
</script>
-
</div>
 
-
</td>
+
</head>
-
</tr>
+
-
</table>
+
-
</td>
+
<!-- ******************************************************************* -->
-
</tr>
+
<!-- Body -->
 +
<!-- ******************************************************************* -->
-
<!-- **************************************************************************************************************************************************
 
-
CAS 9
 
-
************************************************************************************************************************************************** -->
 
-
<tr>
+
<body>
-
<td>
+
-
<a href="#trennlinie2"><img id="trennlinie" src="https://static.igem.org/mediawiki/2013/1/16/Trennlinie_freiburg_13.png"></a>
+
<div id="content_main">
 +
<p id="h1">
 +
HIGHLIGHTS
 +
</p>
 +
<center><p style="color:grey">Slider may take a while to load. Please be patient!</p></center>
 +
        <div class="flexslider">
 +
            <ul class="slides">
 +
             
 +
<!-- 6 opportunities -->           
 +
<li >
 +
                    <div class="frontpage-slide" style="margin-top:-25px;">  <div id="left_column" style="margin-left:50px;">
-
<table id="tabelle">
 
-
<tr>
 
-
<td>
 
-
<div id="left_column">
 
-
<div style="text-align: center;">
+
<p id="headline";">  
-
<EMBED  HEIGHT=460 WIDTH=450 TYPE="video/quicktime"
+
9 opportunities of our uniCAS toolkit
-
PLUGINSPAGE="http://www.apple.com/quicktime/download/"  
+
</p>
-
SRC="https://static.igem.org/mediawiki/2013/b/be/Cas_binding.mov"
+
<p>We provide <a id="link" href="https://2013.igem.org/Team:Freiburg/Project/effector">3 different effectors</a> to efficiently activate or repress genes in mammalian cells. Our toolkit also comprises devices for controlling effectors by <a id="link" href="https://2013.igem.org/Team:Freiburg/Project/induction#light">light stimuli</a>. We furthermore constructed a light box called <a id="link" href="https://2013.igem.org/Team:Freiburg/Project/unibox">uniBOX</a> to conduct light experiments. Use our custom-tailored <a id="link" href="https://2013.igem.org/Team:Freiburg/Project/toolkit">Manual Tool</a> to generate detailed instructions for your own CRISPR/Cas9 based gene regulation experiment. With our toolkit and the standardized RNA-plasmid, termed <a id="link" href="https://2013.igem.org/Team:Freiburg/Project/crrna#rnaimer">RNAimer</a>, it is possible to target not only one, but <a id="link" href="https://2013.igem.org/Team:Freiburg/Project/crrna#multiple_targeting">multiple genes</a> of interest. We also developed <a id="link" href="https://2013.igem.org/Team:Freiburg/Project/method">uniBAss</a> - our universal binding assay for assessing the binding capacity of our fusion proteins. With our <a id="link" href="https://2013.igem.org/Team:Freiburg/Project/modeling">modeling data</a> we concluded how to optimize our system - by <a id="link" href="https://2013.igem.org/Team:Freiburg/Project/truncation">truncating dCas9</a>.</p>
-
AUTOPLAY="false"/></OBJECT>  
+
-
</div>
+
</div>
</div>
-
</td>
+
                        <div class="slide-right-col"><div id="right_column">               
-
<td>
+
<a href="https://2013.igem.org/Team:Freiburg/Project/1"><img id="main_images" src="https://static.igem.org/mediawiki/2013/e/e8/9_reasons_to_love_our_system_freiburg_2013_klein.png" style="width:400px; margin-left:130px; margin-top:-443px;"> </a>
-
<div id="right_column">
+
                         
-
<p id="headline">  
+
                        </div></div>
-
dCas9 - The Heart of our toolkit  
+
                        <div class=clear></div>
 +
                    </div>
 +
                </li>
 +
 
 +
<!-- dCas9 Heart -->
 +
                <li>
 +
                    <div class="frontpage-slide" style="margin-top:-11px;">
 +
                        <div id="left_column"> <p id="headline"> <a href="http://parts.igem.org/Part:BBa_K1150000"><img src="https://static.igem.org/mediawiki/2013/9/90/Freiburg-2013-Highlights-Heart.png" style="width:65px; margin-top:-17px; margin-left:-4px; "> </a>
 +
dCas9 - The heart of our toolkit  
</p>
</p>
-
<p>
+
<p>The CRISPR/Cas9 system relies on a protein-RNA-DNA interaction between the Cas9 protein, two non-coding RNAs and the appropriate DNA. The 160 kDa Cas9 protein was <a id="link" href="https://2013.igem.org/Team:Freiburg/Project/1#introduction">mutated</a> to inactivate the DNA cleavage site. The standardization for the iGEM community was done by introducing 10 mutations into the <i>Cas9</i> gene, resulting in the DNA-binding protein dCas9 found in the <a id="link" href="http://parts.igem.org/Part:BBa_K1150000">parts registry</a>. This is the heart of our toolkit: A protein that allows for multiple and sequence-specific DNA binding. By fusing several effector domains to dCas9, we constructed novel engineered proteins for efficient gene regulation. <i>Read more in the next slides</i>.</p>
-
We started by mutating the DNA cleavage site in the Cas9 protein and generated a DNA binding protein that is relying on a Protein-RNA-DNA interaction. This simple DNA binding protein is the foundation of our project and all effectors used in this toolkit are fused to it.
+
-
<img src="https://static.igem.org/mediawiki/2013/f/f4/Dna_freiburg_13_ruppel_die_katz.png" style="width:650px; margin-top:110px; margin-left:-106px;">
+
-
</div>
+
-
</td>
+
-
</tr>
+
-
</table>
+
-
</td>
 
-
</tr>
 
-
<tr>
 
-
<td>
 
-
<img id="trennlinie" src="https://static.igem.org/mediawiki/2013/1/16/Trennlinie_freiburg_13.png">
 
 +
</div>
 +
</div>
 +
                        <div class="slide-right-col" style="margin-top:-450px; margin-right:-1px;">
 +
                            <div id="right_column"> <div style="text-align: center;">
-
<!-- **************************************************************************************************************************************************
+
<a href="http://parts.igem.org/Part:BBa_K1150000"><img src="https://static.igem.org/mediawiki/2013/b/b6/Poster_Cas_Freiburg_2013.png" style="width:500px; margin-left:30px;"> </a>
-
ACTIVATION
+
</div>
-
************************************************************************************************************************************************** -->
+
</div>
 +
                        <div class=clear></div>
 +
                    </div>
 +
                </li>  
 +
<!-- Multiple Targeting -->   
 +
<li>
 +
                    <div class="frontpage-slide">
 +
                        <div id="left_column">
 +
<p id="headline" > <a href="https://2013.igem.org/Team:Freiburg/Project/crrna"> <img src="https://static.igem.org/mediawiki/2013/b/bb/Freiburg_2013_main2_Multiple_Targeting.png" style="height:65px; width:65px; margin-top:-34px; margin-left:-4px; "> </a>
 +
Multiple Targeting
 +
</p>
 +
<p>
 +
One of the greatest advantages of the CRISPR/Cas9 system is that only one protein is necessary for targeting of various DNA sequences. The only component which needs to be replaced is the CRISPR-RNA (crRNA). We therefore designed an RNA plasmid termed the <a id="link" href="https://2013.igem.org/Team:Freiburg/Project/crrna#rnaimer">RNAimer</a>. It provides the backbone for easily exchanging the sequence for these crRNAs. Functional tests showed that the RNAimer plasmid works efficiently in mammalian cells.  For multiple targeting, different crRNAs can be combined into one RNAimer plasmid. Gene regulation worked even more efficiently when using multiple targets. <a id="link" href="https://2013.igem.org/Team:Freiburg/Project/crrna">Read more!</a> </p>
-
<table id="tabelle">
 
-
<tr>
 
-
<td>
 
 +
</div>
 +
                        <div class="slide-right-col" style="margin-top:-450px; margin-right:-1px;">
 +
                            <div id="right_column">
-
<div id="left_column">
+
<div>
-
<p id="headline">  
+
<table id="Fig8" class="imgtxt" style="margin-top:111px; margin-right:-10px;">
-
Activation
+
<tbody><tr>
-
</p>
+
<td> <a href="https://2013.igem.org/Team:Freiburg/Project/crrna#rnaimer"> <img  style="width:580px; margin-left:-5px; margin-top:20px;" src="https://static.igem.org/mediawiki/2013/c/c6/Multiple_Targeting_Freiburg_2013.png"> </a> </td>
-
<p>
+
</tr>
-
The activation domain VP16 is able to activate transcription of genes. We achieved up to 30-fold activation.
+
-
</p>
+
</tbody></table>
 +
</div>
-
</div>
 
-
</td>
+
</div>
-
<td>
+
                        </div>
-
<div id="right_column">
+
                        <div class=clear></div>
 +
                    </div>
 +
                </li>
-
<img style="width:500px" src="https://static.igem.org/mediawiki/2013/8/8a/Freiburg_2013_Highlights_Bild1.png">
+
<!-- Activation-->   
 +
<li>
 +
                    <div class="frontpage-slide"><div id="left_column">
 +
<p id="headline"> <a href="https://2013.igem.org/Team:Freiburg/Project/effector#activation"> <img src="https://static.igem.org/mediawiki/2013/0/03/Freiburg_2013_main2_Activation.png" style="height:65px; width:65px; margin-top:-24px; margin-left:-4px; "> </a>
 +
Activation
 +
</p>
 +
<p>We fused dCas9 to the trans-activation domain VP16. This fusion protein is able to activate gene expression from a minimal CMV promoter. The fusion protein was successfully tested in mammalian cells and used to activate the secreted embryonic alkaline phosphatase (SEAP) reporter gene expression. We achieved an over 25-fold upregulation of SEAP expression by targeting sequences located upstream of the promoter. Numbers characterizing the crRNAs in the graph represent the distance from the translation start site. <a id="link" href="https://2013.igem.org/Team:Freiburg/Project/effector#activation">Read more!</a></p>
 +
                     
 +
</div> 
 +
                        <div class="slide-right-col" style="margin-top:-400px; margin-right:-40px;">
 +
                              <div id="right_column"> 
 +
<div>
 +
<table class="imgtxt">
 +
<tbody><tr>
 +
<td> <a href="https://2013.igem.org/Team:Freiburg/Project/effector#activation"><img  src="https://static.igem.org/mediawiki/2013/6/66/VP16-Freiburg-2013.png" style="width:450px;"> </a> </td>
 +
</tr>
 +
 +
</tbody></table>
</div>
</div>
-
</td>
 
-
</tr>
 
-
</table>
 
-
</td>
 
-
</tr>
 
-
<tr>
+
                    </div>
-
<td>
+
</div>
 +
                        <div class=clear></div>
 +
                    </div>
 +
                </li> 
-
<img id="trennlinie" src="https://static.igem.org/mediawiki/2013/1/16/Trennlinie_freiburg_13.png">
 
-
<!-- **************************************************************************************************************************************************
 
-
REPRESSION
 
-
************************************************************************************************************************************************** -->
 
-
<table id="tabelle">
+
<!-- G9a -->
-
<tr>
+
<li>
-
<td>
+
                    <div class="frontpage-slide">
-
<div id="left_column">
+
                      <div id="left_column">
-
 
+
<p id="headline"> <a href="https://2013.igem.org/Team:Freiburg/Project/effector#epigenetics"><img src="https://static.igem.org/mediawiki/2013/3/31/Freiburg_2013_main2_Epigenetic.png" style="height:65px; width:65px; margin-top:-34px; margin-left:-4px; "> </a>
-
<img src="https://static.igem.org/mediawiki/2013/7/7c/Freiburg_2013_Highlights_Bild2.png" style="width:500px">
+
Epigenetic Repression
-
 
+
-
 
+
-
</div>
+
-
</td>
+
-
<td>
+
-
<div id="right_column" style="margin-top:-30px">
+
-
<p id="headline">  
+
-
Repression  
+
</p>
</p>
-
<p>
+
<p >
-
The fusion of the transcriptional repressor domain KRAB leads to synthetic repression of gene expression. With this construct a strong repression could be observed.
+
<p >
 +
Specific chromatin modification was achieved by fusing the histone methyltransferase G9a to dCas9 and thereby contributing an epigenetic BioBrick. G9a primarily methylates histone H3. Different endogenous VEGF loci were targeted in mammalian cells. This resulted in an up to 50% repression (*, p<0.05) in which VEGF-8 corresponds to a region in the VEGF locus at position -8 bp from the transcription start site (TSS) and VEGF-573 corresponds to a region -573 bp from the TSS. <a id="link" href="https://2013.igem.org/Team:Freiburg/Project/effector#epigenetics"> Read more!</a>
</p>
</p>
-
</div>
 
-
</td>
 
-
</tr>
 
-
</table>
 
-
</td>
 
-
</tr>
 
-
<tr>
 
-
<td>
 
-
<img id="trennlinie" src="https://static.igem.org/mediawiki/2013/1/16/Trennlinie_freiburg_13.png">
+
</div>
 +
                        <div class="slide-right-col" style="margin-top:-58px; margin-right:-50px;">
 +
                            <div id="right_column">
-
<!-- **************************************************************************************************************************************************
+
<div>
 +
<table id="Fig8" class="imgtxt">
 +
<tbody><tr>
 +
<td> <a href="https://2013.igem.org/Team:Freiburg/Project/effector#epigenetics"><img  src="https://static.igem.org/mediawiki/2013/b/bf/G9a-Freiburg-2013.png" style="width:420px;"> </a> </td>
 +
</tr>
 +
 +
</tbody></table>
 +
</div> 
-
EPIGENETICS
 
-
************************************************************************************************************************************************** -->
+
</div>
 +
                        <div class=clear></div>
 +
                    </div>
 +
                </li>   
 +
<!-- Repression KRAB -->   
 +
<li>
 +
                    <div class="frontpage-slide">
 +
                      <div id="left_column">
-
 
+
<p id="headline"> <a href="https://2013.igem.org/Team:Freiburg/Project/effector#repression"> <img src="https://static.igem.org/mediawiki/2013/e/e7/Repression_freiburg_13.png" style="height:65px; width:65px; margin-top:-34px; margin-left:-4px; "> </a>
-
 
+
Repression  
-
<table id="tabelle">
+
-
<tr>
+
-
<td>
+
-
 
+
-
 
+
-
<div id="left_column">
+
-
<p id="headline">  
+
-
Chromatin modification (Repression)
+
</p>
</p>
<p>
<p>
-
Specific chromatin modification was achieved by fusing the histone methyltransferase G9a to dCas9. With this protein we are able to specifically repress endogenous gene expression.
+
The transcriptional repressor domain Krüppel associated box (KRAB) was fused to dCas9. Thus, a transcriptional repressor with the flexibility to target any DNA sequence of interest was engineered. The device was tested in mammalian cells to target endogenous VEGF loci. An up to 50% repression was achieved when targeting different DNA sites. The numbers characterizing the crRNAs represent the distance from the transcription start site. <a id="link" href="https://2013.igem.org/Team:Freiburg/Project/effector#repression">Read more!</a>
</p>
</p>
-
</div>
 
-
</td>
+
</div>
-
<td>
+
                        <div class="slide-right-col" style="margin-top:-48px; margin-right:-50px;">
-
<div id="right_column">
+
                            <div id="right_column">
 +
<!-- <img src="https://static.igem.org/mediawiki/2013/2/20/Freiburg2013-Highlights-KRAB3.png" style="width:500px"> -->
-
<img style="width:500px" src="https://static.igem.org/mediawiki/2013/0/0d/G9a_Highlights_Freiburg_2013.JPG">
+
<div>
 +
<table id="Fig8" class="imgtxt">
 +
<tbody><tr>
 +
<td> <a href="https://2013.igem.org/Team:Freiburg/Project/effector#repression"> <img src="https://static.igem.org/mediawiki/2013/5/5b/KRAB-Freiburg-2013.png" style="width:450px"></a> </td>
 +
</tr>
 +
 +
</tbody></table>
 +
</div>
</div>
</div>
-
</td>
+
                        <div class=clear></div>
-
</tr>
+
                    </div>
-
</table>
+
                </li>    
-
</td>
+
-
</tr>
+
-
<tr>
 
-
<td>
 
-
<img id="trennlinie" src="https://static.igem.org/mediawiki/2013/1/16/Trennlinie_freiburg_13.png">
 
 +
<!-- Light -->   
 +
<li>
 +
                    <div class="frontpage-slide">
 +
                        <div id="left_column">
-
<!-- **************************************************************************************************************************************************
+
<p id="headline" > <a href="https://2013.igem.org/Team:Freiburg/Project/induction#light"> <img src="https://static.igem.org/mediawiki/2013/9/9a/Freiburg_2013_main2_Licht.png" style="height:65px; width:65px; margin-top:-34px; margin-left:-4px; "> </a>
 +
Light control
 +
</p>
 +
<p>
 +
We aimed to control our system with light to allow gene regulation with high spatiotemporal resolution. We engineered a system for induction by red, UVB and blue light. The blue light system is based on the light-triggered interaction of CRY2 and CIB1. CRY2 was fused to dCas9 which - upon light-stimulus - can recruit the CIB1-VP16 fusion protein to any DNA sequence of interest. A 5-fold upregulation of SEAP reporter was achieved (*, p<0.05). dCas9-CRY2 was targeted simultaneously to four DNA sites upstream of the promoter. Numbers characterizing the crRNAs represent the distance from the translation start site.
 +
<a id="link" href="https://2013.igem.org/Team:Freiburg/Project/induction#light">Read more!</a> </p>
-
UNIBASS
 
-
************************************************************************************************************************************************** -->
 
 +
</div>
 +
                        <div class="slide-right-col" style="margin-top:15px; margin-right:-50px;">
 +
                            <div id="right_column">
-
<table id="tabelle">
 
-
<tr>
 
-
<td>
 
-
<div id="left_column">
 
-
 
-
<!--<img src="https://static.igem.org/mediawiki/2013/f/f6/UniBASS_Freiburg_2013.JPG" style="width:500px">-->
 
<div>
<div>
-
<img style="width:440px; position:absolute; left:50px; top:4090px; z-index:2" src="https://static.igem.org/mediawiki/2013/1/17/Freiburg_2013_highlights_Rahmen.png" >
+
<table id="Fig8" class="imgtxt" style="margin-top:-41px; margin-right:-10px;">
 +
<tbody><tr>
 +
<td> <a href="https://2013.igem.org/Team:Freiburg/Project/induction#light"> <img  src="https://static.igem.org/mediawiki/2013/b/bc/Light-Freiburg-2013-Highlight-Boston.png" style="width:450px"> </a> </td>
 +
</tr>
 +
 +
</tbody></table>
 +
</div>
-
<div style="position:absolute; left:70px;top:4100px; z-index:1">
 
-
<EMBED  HEIGHT=362 WIDTH=400 TYPE="video/quicktime" 
 
-
PLUGINSPAGE="http://www.apple.com/quicktime/download/" 
 
-
SRC="https://static.igem.org/mediawiki/2013/a/a1/Freiburg_2013_highlights_UniBAss_400.mov" 
 
-
AUTOPLAY="false"/></OBJECT>
 
-
</div>
 
-
</div>
 
-
</div>
 
-
</td>
 
-
<td>
 
-
<div id="right_column" style="margin-top:-150px">
 
-
<p id="headline" >
 
-
uniBAss - Binding Assay</p>
 
-
<p>
 
-
We developed a novel and innovative ELISA based method to quantify the binding efficiency of our proteins. We called this binding assay uniBAss. This is a powerful tool for characterizing the modified dCas9 by assessing its DNA binding capacity with high throughput capabilities.
 
-
</p>
 
</div>
</div>
-
</td>
+
                        </div>
-
</tr>
+
                        <div class=clear></div>
-
</table>
+
                    </div>
 +
                </li>
-
</td>
+
<!-- uniBOX -->  
-
</tr>
+
<li>
-
 
+
                    <div class="frontpage-slide"><div id="left_column">
-
</table>
+
<p id="headline"> <a href="https://2013.igem.org/Team:Freiburg/Project/unibox"> <img src="https://static.igem.org/mediawiki/2013/9/9f/UniBOX-logo-Freiburg-2013.png" style="height:65px; width:72px; margin-top:-24px; margin-left:2px; "> </a>
 +
uniBOX - A LEGO built light box
 +
</p>
 +
<p> Light inducible systems are more and more used in iGEM and synthetic biology in general. Our gene regulation system is controllable via light as well. Therefore we thought of an easy and affordable way to build a light box to illuminate our cells with a certain wavelength. But construction of such a light box can be hard because there are certain problems you have to face. Our so called uniBOX can be built by using common things like LEGO bricks, glass, foil and LEDs. We were able to show that light systems can be controlled efficiently and we now provide a do-it-yourself manual for building your own uniBOX! <a id="link" href="https://2013.igem.org/Team:Freiburg/Project/unibox">Read more and take a look at our manual!</a></p>
 +
                     
 +
</div> 
 +
                        <div class="slide-right-col" style="margin-top:10px; margin-right:-102px;">
 +
                              <div id="right_column"> 
 +
<div>
 +
<table class="imgtxt">
 +
<tbody><tr>
 +
<td> <a href="https://2013.igem.org/Team:Freiburg/Project/unibox"><img  src="https://static.igem.org/mediawiki/2013/0/05/UniBOX-iGEM-Highlights-2013-Freiburg.png" style="width:350px;"> </a> </td>
 +
</tr>
 +
 +
</tbody></table>
 +
</div>
 +
                    </div>
 +
</div>
 +
                        <div class=clear></div>
 +
                    </div>
 +
                </li> 
 +
<!-- Modeling -->   
 +
<li>
 +
                    <div class="frontpage-slide"><div id="left_column">
 +
<p id="headline"> <a href="https://2013.igem.org/Team:Freiburg/Project/modeling"> <img src="https://static.igem.org/mediawiki/2013/f/fd/Modeling-Logo-Freiburg-2013.png" style="height:56px; width:59px; margin-top:-24px; margin-left:2px; "> </a>
 +
Modeling
 +
</p>
 +
<p> We used a kinetic approach to model and characterize our system. It is based on various ordinary differential equations which describe the behaviour of our network. To optimize our system we varied dCas9 production rates and noticed that especially a higher expression rate of dCas9 was able to increase the efficiency of the system. Since dCas9 is a large protein, consisting of 160 kDa, expression rate of a smaller truncated version would be higher. See the next slide for truncation ideas and results. <a id="link" href="https://2013.igem.org/Team:Freiburg/Project/modeling">Read more about our modeling!</a></p>
 +
                     
 +
</div> 
 +
                        <div class="slide-right-col" style="margin-top:-290px; margin-right:10px;">
 +
                              <div id="right_column"> 
 +
<div>
 +
<table class="imgtxt">
 +
<tbody><tr>
 +
<td> <a href="https://2013.igem.org/Team:Freiburg/Project/modeling"><img  src="https://static.igem.org/mediawiki/2013/c/c0/Plot_verschiedenReaktionsraten.png" style="width:480px;margin-left:70px;margin-top:-40px;"> </a> </td>
 +
</tr>
 +
 +
</tbody></table>
 +
</div>
 +
                    </div>
 +
</div>
 +
                        <div class=clear></div>
 +
                    </div>
 +
                </li> 
-
<!--
 
-
<table id="tabelle">
+
<!-- Truncation -->  
-
<tr>
+
<li>
-
<td>
+
                    <div class="frontpage-slide"><div id="left_column">
-
<div id="left_column">
+
<p id="headline"> <a href="https://2013.igem.org/Team:Freiburg/Project/truncation"> <img src="https://static.igem.org/mediawiki/2013/e/e2/Truncation-kleines-Symbol-Freiburg-2013.png" style="height:75px; width:75px; margin-top:-33px; margin-left:-4px; "> </a>
-
<p id="headline">  
+
Truncation
-
6 Reasons for loving the uniCAS toolkit
+
</p>
</p>
-
<p>
+
<p> To increase the efficiency of our system we truncated the dCas9 protein at different sites and various extent. Expression rates of smaller proteins were higher as showed in the western blots. In accordance with our modeling this should lead to a higher rate of gene activation or repression. However our functional tests of the truncated proteins were yet inconclusive. <a id="link" href="https://2013.igem.org/Team:Freiburg/Project/truncation">Read more!</a></p>
-
All you need to realize your personal experiments are 6 smart amazingly easy to use tools that come with the uniCAS toolkit. Just use our custom-tailored <a id="link" href="https://2013.igem.org/Team:Freiburg/Project/toolkit"> uniTOOL </a> to generate individual manuals. Best of all: It´s all open source and non commercial!
+
                     
-
</p>
+
-
</td>
+
-
<td>
+
-
<div id="right_column">
+
-
<img id="main_images" src="https://static.igem.org/mediawiki/2013/0/05/Sdfvsdfvdssdfvsdfv2.png" style="width:500px;">
+
</div>
 +
                        <div class="slide-right-col" style="margin-top:5px; margin-right:-65px;">
 +
                              <div id="right_column"> 
 +
<div>
 +
<table class="imgtxt">
 +
<tbody><tr>
 +
<td> <a href="https://2013.igem.org/Team:Freiburg/Project/truncation"><img  src="https://static.igem.org/mediawiki/2013/0/05/Truncation-Highlight-Freiburg-2013.png" style="width:450px;"> </a> </td>
 +
</tr>
 +
 +
</tbody></table>
</div>
</div>
-
</td>
 
-
</tr>
 
-
</table>
 
-
-->
+
                    </div>
 +
</div>
 +
                        <div class=clear></div>
 +
                    </div>
 +
                </li> 
 +
 
 +
<!-- uniBAss -->   
 +
<li>
 +
                    <div class="frontpage-slide" >  <div id="left_column" style="margin-left:5px;">
 +
<p id="headline"><a href="https://2013.igem.org/Team:Freiburg/Project/method"> <img src="https://static.igem.org/mediawiki/2013/e/ef/UniBAss_freiburg_13.png" style="height:65px; width:65px; margin-top:-34px; margin-left:-4px; "> </a>
 +
uniCAS Binding Assay - uniBAss
 +
</p>
 +
<p>We developed a novel and innovative ELISA-based method to quantify the binding efficiencies of our dCas9 fusion proteins: The uniCAS Binding Assay (uniBAss). Biotinylated oligos are coated on 96-well ELISA plates via the interaction with streptavidin and bound dCas9/RNA complexes can be detected via antibodies. We were able to show that this is a powerful tool to characterize the modified dCas9 fusion proteins by assessing their DNA binding capacity with possible improvements for high-throughput screenings. <a id="link" href="https://2013.igem.org/Team:Freiburg/Project/method">Read more!</a>
 +
</p>
 +
             
 +
</div>                   
 +
                        <div class="slide-right-col" > 
 +
<div id="right_column" style="margin-left:70px;">
-
<!--
+
<!--<img src="https://static.igem.org/mediawiki/2013/f/f6/UniBASS_Freiburg_2013.JPG" style="width:500px">-->
-
<div id="content_main">
+
-
<div id="text1">
+
<div>
 +
<table class="imgtxt" width="500px">
 +
<tbody><tr>
 +
<td>
 +
<div>
 +
<a href="https://2013.igem.org/Team:Freiburg/Project/method"><img style="width:400px; margin-left:20px; margin-top:-418px;" src="https://static.igem.org/mediawiki/2013/c/c2/Freiburg2013-Highlights-uniBAss-1.png" > </a>
 +
</div></td>
 +
</tr>
 +
</tbody></table>
 +
</div>
-
<p id="h1">Highlights
+
           
-
</p>
+
-
<p id="h2">In the last months we were able to...</p>
+
</div>
 +
                        </div>
 +
                        <div class=clear></div>
 +
                    </div>
 +
                </li>
-
<ul style="font-size:20px">
 
-
    <li>...constuct a <b>catalytically inactive version of Cas9</b> and this way generate a new class of DNA binding proteins.</li>
 
-
    <li>...combine this modified dCas9 with <b>different transcriptional effectors</b>.</li>
 
-
    <li>...express this system in various <b>mammalian cell lines</b>.</li>
 
-
    <li>...control human <b>gene expression</b> via our modified CRISPR/Cas system.</li>
 
-
    <li>...regulate gene expression on <b>light stimulus</b>.</li>
 
-
    <li>...make our <b>dCas9 accesible to the whole iGEM comunity</b> by mutating illegal iGEM restriction sites</b>.</li>
 
-
<br>
 
-
In summary we build up a <b>universal toolkit for gene regulation</b>.
 
 +
<!-- Manual -->   
 +
<li>
 +
                    <div class="frontpage-slide" >
 +
                        <div id="left_column">
-
</ul>
+
<p id="headline" > <a href="https://2013.igem.org/Team:Freiburg/Project/toolkit"> <img src="https://static.igem.org/mediawiki/2013/5/5d/Freiburg_2013_main2_Toolkitnew.png" style="height:65px; width:65px; margin-top:-34px; margin-left:-4px; "> </a>
-
 
+
Manual
-
<p id="h3">In the beginning
+
</p>
</p>
-
<p>
+
<p>As we believe that our engineered CRISPR/Cas9 system is a promising tool for targeted gene regulation, we would like to offer a manual to the iGEM community for facilitated usage of our toolkit. Therefore we designed an interactive <a id="link" href="https://2013.igem.org/Team:Freiburg/Project/toolkit">Manual Tool</a> that generates detailed descriptions for your own gene regulation experiments dependent on whether you would like to efficiently repress or activate gene expression. We provide all our experimental knowledge and optimized protocols to everyone who would like to use our uniCAS toolkit. <a id="link" href="https://2013.igem.org/Team:Freiburg/parts/sharing">Read more!</a></p>
-
A mutated Cas9 derived protein without nickase function was our start. This is basically a DNA binding protein, that is relying on a <b>protein-RNA-DNA</b>  
+
</div>
-
interaction.
+
                        <div class="slide-right-col" style="margin-top:0px; margin-right:-50px;">
-
</p><p></p><p>
+
                            <div id="right_column">
-
By fusing <b>effector domains</b> to dCas9 we altered the properties in various ways.</p>
+
-
<p id="h3">Activation
 
-
</p>
 
-
 
-
<div style="position:absolute; top:1000px; left:550px;"> <img style="height:200px" src="https://static.igem.org/mediawiki/2013/f/f4/Freiburg_2013_highlights_Activation-Pfeil.png"> </div>
 
-
<p> The <b>activation domain VP16</b> is able to activate transcription of
 
-
 
-
genes.<p></p>
 
<div>
<div>
-
<table class="imgtxt" width="500px">
+
<tableclass="imgtxt" style="margin-top:-51px; margin-right:-10px;">
-
<tr>
+
<tbody><tr>  
-
<td> <img class="imgtxt" width="500px" src="https://static.igem.org/mediawiki/2013/5/59/VP16_Highlights_Freiburg_2013.JPG"> </td>
+
<td> <a href="https://2013.igem.org/Team:Freiburg/Project/toolkit"> <img  style="margin-top:57px; margin-left:25px;" src="https://static.igem.org/mediawiki/2013/6/63/Freiburg-2013-Highlights-Manual.png" style="width:450px"> </a> </td>
-
</tr>
+
</tr>
-
<tr>
+
-
<td> <b>Figure 1: Activation by Cas9:VP16 </b><br>
+
</tbody></table>
-
By fusing the transcriptional activation domain VP16 to dCas9, we are able to activate a SEAP reporter transcription.
+
</div>
-
</td>
+
-
</tr>
+
-
</table>
+
</div>
</div>
 +
                        </div>
 +
                        <div class=clear></div>
 +
                    </div>
 +
                </li> 
-
<p id="h3"> Repression
+
 
 +
<!-- Application -->   
 +
<li>
 +
                    <div class="frontpage-slide"><div id="left_column">
 +
<p id="headline"> <a id="link" href="https://2013.igem.org/Team:Freiburg/Project/application">
 +
Application </a>
</p>
</p>
 +
<p> Our uniCAS toolkit is a versatile applicable tool. Every expert we talked to had amazing ideas concerning application in their own research!</p>
 +
<p> “… the use of this toolkit may help us in understanding complex metabolomes, because many enzymes can be regulated at once …” - Prof. Dr. Hess, Genetics of Cyanobacteria </p>
 +
<p> “... I would use this kit to understand the transcriptional codes of brain development better, by simultaneously regulating various promoters of neural transcription factors ...“ - Dr. Jochen Holzschuh, Neuronal Development </p>
 +
<p> <a id="link" href="https://2013.igem.org/Team:Freiburg/Project/application">Read more!</a></p>
 +
                     
-
<div style="position:absolute; top:1550px; left:550px;"> <img style="height:200px" src="https://static.igem.org/mediawiki/2013/2/2f/Freiburg_2013_highlights_Repression-Pfeil.png"> </div>
+
</div>
-
 
+
-
 
+
-
The fusion of the <b>transcriptional repressor domain KRAB</b> leads to synthetic repression of gene expression.<p></p>
+
 +
                        <div class="slide-right-col" style="margin-top:20px; margin-right:-80px;">
 +
                              <div id="right_column"> 
<div>
<div>
-
<table class="imgtxt" width="500px">
+
<table class="imgtxt">
-
<tr>
+
<tbody><tr>  
-
<td> <img class="imgtxt" width="500px" src="https://static.igem.org/mediawiki/2013/5/52/KRAB_Highlights_Freiburg_2013.JPG"> </td>
+
<td> <a href="https://2013.igem.org/Team:Freiburg/Project/application"><img  src="https://static.igem.org/mediawiki/2013/a/a6/Experts_Highlights_Freiburg_2013.png" style="width:360px;"> </a> </td>
-
</tr>
+
</tr>
-
<tr>
+
-
<td> <b>Figure 2: Repression via dCas9:KRAB </b><br>
+
</tbody></table>
-
Using dCas9:KRAB we were able to repress GFP expression in mammalian cells.
+
-
</td>
+
-
</tr>
+
-
</table>
+
</div>
</div>
-
<p id="h3">Chromatin modification (Repression)
+
                    </div>
-
</p>
+
</div>
 +
                        <div class=clear></div>
 +
                    </div>
 +
                </li>
-
<div style="position:absolute; top:2050px; left:550px;"> <img style="height:200px" src="https://static.igem.org/mediawiki/2013/2/2f/Freiburg_2013_highlights_Repression-Pfeil.png"> </div>
 
-
Specific <b>chromatin modification</b> was
+
<!-- Human Practice -->  
-
 
+
<li>
-
achieved by fusing a histone methyltransferase G9a to dCas9. With this protein we are able to specifically repress endogenous gene expression. </p> <p>
+
                    <div class="frontpage-slide">
 +
                        <div id="left_column">
 +
<p id="headline" > <a href="https://2013.igem.org/Team:Freiburg/HumanPractice"> <img src="https://static.igem.org/mediawiki/2013/a/ad/Human_Practice_Logo_Frieburg_2013.png" style="height:65px; width:65px; margin-top:-34px; margin-left:-4px; "> </a>
 +
Human Practice & Outreach
 +
</p>
 +
<p>In case of safety and ethical issues concerning our project we consulted many biology experts and asked for their opinion and advice. Next we connected synthetic biology with art and music as all the three disciplines require creativity, technical skills and a lot of commitment and also art & music can be used to address a lot of people. We further organized several events to inform about synthetic biology and our project. We went to a political party and schools, participated at an ethical seminar, a science fair and collaborated with other German teams to organize the SynBio Day. <a id="link" href="https://2013.igem.org/Team:Freiburg/HumanPractice">Read more!</a></p>
 +
</div>
 +
                        <div class="slide-right-col" style="margin-top:15px; margin-right:-62px;">
 +
                            <div id="right_column" >
<div>
<div>
-
<table class="imgtxt" width="500px">
+
<tableclass="imgtxt" >
-
<tr>
+
<tbody><tr>  
-
<td> <img class="imgtxt" width="500px" src="https://static.igem.org/mediawiki/2013/0/0d/G9a_Highlights_Freiburg_2013.JPG"> </td>
+
<td> <a href="https://2013.igem.org/Team:Freiburg/HumanPractice"> <img  src="https://static.igem.org/mediawiki/2013/e/e3/Human_Practice_Highlights_Pictures_Freiburg_2013.png" style="width:430px"> </a> </td>
-
</tr>
+
</tr>
-
<tr>
+
-
<td> <b>Figure 3: Endogenous, stable repression by dCas9:G9a </b><br>
+
</tbody></table>
-
Chromatin remodeling, resulting in repression of endogenous genes is possible by fusing the histone methyltransferase G9a to dCas9.
+
</div>
-
</td>
+
-
</tr>
+
-
</table>
+
</div>
</div>
 +
                        </div>
 +
                        <div class=clear></div>
 +
                    </div>
 +
                </li> 
-
</p> <p> </p> <p>
 
-
<p id="h3">Light switch
+
<!-- Übersicht -->   
-
</p>
+
<li>
 +
                  <div class="frontpage-slide">
 +
                     
-
We were able to induce our system on <b>light stimulus</b>. This was possible by using photoreceptors of higher plants.
+
<div id="preample">  
-
</p> <p> </p> <p>
+
<p id="h4" style="color:#ffcc00;  font-style:italic; font-size:20px; text-align:center">To summarize - In the last months we were able to ...</p>
-
<p id="h3">Targeting with RNAimer
+
<ul style="font-size:18px; margin-left:20px;">
-
</p>
+
-
By building a plasmid containing the necessary<b> RNAs</b> and <b>insertion sites</b> for targeting we created a modular, BioBrick compatible system for <b>multiple
+
-
DNA targeting: The RNAimer.</b>
+
    <li> construct a catalytically inactive version of Cas9 (dCas9) and thus generate a DNA binding protein.</li>
-
Using our RNAimer plasmid it is easy to combine several target sequences on one plasmid using the BioBrick standard.
+
    <li> make our <a id="link" href="http://parts.igem.org/Part:BBa_K1150000">dCas9</a> accessible to the whole iGEM community by mutating 10 illegal iGEM restriction sites.</li>
-
</p> <p> </p> <p>
+
    <li> combine this modified dCas9 with different transcriptional <a id="link" href="https://2013.igem.org/Team:Freiburg/Project/effector">effectors</a> and express them in mammalian cell lines.</li>
 +
    <li> control mammalian gene expression via our modified CRISPR/Cas9 fusion proteins.</li>
 +
    <li> build devices for controlling gene expression by different <a id="link" href="https://2013.igem.org/Team:Freiburg/Project/induction#light">light stimuli</a>.</span>
 +
<li> provide an RNA plasmid termed <a id="link" href="https://2013.igem.org/Team:Freiburg/Project/crrna#rnaimer">RNAimer</a> for facile insertion of crRNAs which target desired DNA sequences.</li>
 +
<li> create an online tool that generates customized <a id="link" href="https://2013.igem.org/Team:Freiburg/Project/toolkit">manuals</a> for easy usage of our toolkit.</li>
 +
    <li> develop a method to assess the DNA binding capacity of our dCas9 fusion proteins - the <a id="link" href="https://2013.igem.org/Team:Freiburg/Project/method#elisa">uniBAss</a>.</li>
 +
<li> <a id="link" href="https://2013.igem.org/Team:Freiburg/Project/modeling">model</a> our system and obtain a possible insight into behavior of measured and unmeasured components, which led us to conclusions how our system could be optimized.</li>
 +
<li> <a id="link" href="https://2013.igem.org/Team:Freiburg/Project/truncation">truncate</a> dCas9 in order to increase expression rate and express these protein versions.</li>
 +
<li> build a cheap and functioning light box, called <a id="link" href="https://2013.igem.org/Team:Freiburg/Project/unibox">"uniBOX"</a>, for light experiments.</li>
 +
</ul>
 +
<p id="h4" style="color:#ffcc00; text-align:center; font-style:italic; font-size:20px;">... design, develop, test and now offer the universally applicable toolkit "uniCAS" for  <br>
-
<p id="h3">uniBAss - Binding Assay
+
<span style="text-align:center">efficient gene regulation to the synthetic biology community. <br></span>
-
</p>
+
-
We developed an ELISA based method. With this method we can quantify the <b>binding efficiency </b>of our proteins. We called this binding assay <b>uniBAss</b>. It is
+
-
a powerful tool for characterizing the modified dCas9 by assessing its DNA binding capacity.
+
<span style="margin-left:-10px">  </span></p>
-
</p> <p>
+
</div>                    
-
<div>
+
                        <div class=clear></div>
-
<table class="imgtxt" width="500px">
+
                    </div>
-
<tr>
+
                </li>
-
<td> <img class="imgtxt" width="500px" src="https://static.igem.org/mediawiki/2013/f/f6/UniBASS_Freiburg_2013.JPG"> </td>
+
 
-
</tr>
+
   
-
<tr>
+
   
-
<td> <b>Figure 4: uniBAss </b><br>
+
            </ul>
-
We developed an assay for testing the binding capacity of our constructs.
+
        </div>
-
</td>
+
-
</tr>
+
-
</table>
+
</div>
</div>
-
</p> <p>
 
-
<p id="h3">Conclusion
 
-
</p>
 
-
<p>We established a new modularized toolkit for modulating gene expression specifically: <b>The uniCAS Toolkit!</b></p><br>
 
-
<img src="https://static.igem.org/mediawiki/2013/d/de/Toolkit_Projekt_Freiburg_2013.PNG" width="700px">
 
-
</div>
 
-
</div>
 
-
-->
 
-
</div>
 
</body>
</body>
-
</style>
 
</html>
</html>

Latest revision as of 14:32, 25 November 2013


HIGHLIGHTS

Slider may take a while to load. Please be patient!

  • 9 opportunities of our uniCAS toolkit

    We provide 3 different effectors to efficiently activate or repress genes in mammalian cells. Our toolkit also comprises devices for controlling effectors by light stimuli. We furthermore constructed a light box called uniBOX to conduct light experiments. Use our custom-tailored Manual Tool to generate detailed instructions for your own CRISPR/Cas9 based gene regulation experiment. With our toolkit and the standardized RNA-plasmid, termed RNAimer, it is possible to target not only one, but multiple genes of interest. We also developed uniBAss - our universal binding assay for assessing the binding capacity of our fusion proteins. With our modeling data we concluded how to optimize our system - by truncating dCas9.

  • dCas9 - The heart of our toolkit

    The CRISPR/Cas9 system relies on a protein-RNA-DNA interaction between the Cas9 protein, two non-coding RNAs and the appropriate DNA. The 160 kDa Cas9 protein was mutated to inactivate the DNA cleavage site. The standardization for the iGEM community was done by introducing 10 mutations into the Cas9 gene, resulting in the DNA-binding protein dCas9 found in the parts registry. This is the heart of our toolkit: A protein that allows for multiple and sequence-specific DNA binding. By fusing several effector domains to dCas9, we constructed novel engineered proteins for efficient gene regulation. Read more in the next slides.

  • Multiple Targeting

    One of the greatest advantages of the CRISPR/Cas9 system is that only one protein is necessary for targeting of various DNA sequences. The only component which needs to be replaced is the CRISPR-RNA (crRNA). We therefore designed an RNA plasmid termed the RNAimer. It provides the backbone for easily exchanging the sequence for these crRNAs. Functional tests showed that the RNAimer plasmid works efficiently in mammalian cells. For multiple targeting, different crRNAs can be combined into one RNAimer plasmid. Gene regulation worked even more efficiently when using multiple targets. Read more!

  • Activation

    We fused dCas9 to the trans-activation domain VP16. This fusion protein is able to activate gene expression from a minimal CMV promoter. The fusion protein was successfully tested in mammalian cells and used to activate the secreted embryonic alkaline phosphatase (SEAP) reporter gene expression. We achieved an over 25-fold upregulation of SEAP expression by targeting sequences located upstream of the promoter. Numbers characterizing the crRNAs in the graph represent the distance from the translation start site. Read more!

  • Epigenetic Repression

    Specific chromatin modification was achieved by fusing the histone methyltransferase G9a to dCas9 and thereby contributing an epigenetic BioBrick. G9a primarily methylates histone H3. Different endogenous VEGF loci were targeted in mammalian cells. This resulted in an up to 50% repression (*, p<0.05) in which VEGF-8 corresponds to a region in the VEGF locus at position -8 bp from the transcription start site (TSS) and VEGF-573 corresponds to a region -573 bp from the TSS. Read more!

  • Repression

    The transcriptional repressor domain Krüppel associated box (KRAB) was fused to dCas9. Thus, a transcriptional repressor with the flexibility to target any DNA sequence of interest was engineered. The device was tested in mammalian cells to target endogenous VEGF loci. An up to 50% repression was achieved when targeting different DNA sites. The numbers characterizing the crRNAs represent the distance from the transcription start site. Read more!

  • Light control

    We aimed to control our system with light to allow gene regulation with high spatiotemporal resolution. We engineered a system for induction by red, UVB and blue light. The blue light system is based on the light-triggered interaction of CRY2 and CIB1. CRY2 was fused to dCas9 which - upon light-stimulus - can recruit the CIB1-VP16 fusion protein to any DNA sequence of interest. A 5-fold upregulation of SEAP reporter was achieved (*, p<0.05). dCas9-CRY2 was targeted simultaneously to four DNA sites upstream of the promoter. Numbers characterizing the crRNAs represent the distance from the translation start site. Read more!

  • uniBOX - A LEGO built light box

    Light inducible systems are more and more used in iGEM and synthetic biology in general. Our gene regulation system is controllable via light as well. Therefore we thought of an easy and affordable way to build a light box to illuminate our cells with a certain wavelength. But construction of such a light box can be hard because there are certain problems you have to face. Our so called uniBOX can be built by using common things like LEGO bricks, glass, foil and LEDs. We were able to show that light systems can be controlled efficiently and we now provide a do-it-yourself manual for building your own uniBOX! Read more and take a look at our manual!

  • Modeling

    We used a kinetic approach to model and characterize our system. It is based on various ordinary differential equations which describe the behaviour of our network. To optimize our system we varied dCas9 production rates and noticed that especially a higher expression rate of dCas9 was able to increase the efficiency of the system. Since dCas9 is a large protein, consisting of 160 kDa, expression rate of a smaller truncated version would be higher. See the next slide for truncation ideas and results. Read more about our modeling!

  • Truncation

    To increase the efficiency of our system we truncated the dCas9 protein at different sites and various extent. Expression rates of smaller proteins were higher as showed in the western blots. In accordance with our modeling this should lead to a higher rate of gene activation or repression. However our functional tests of the truncated proteins were yet inconclusive. Read more!

  • uniCAS Binding Assay - uniBAss

    We developed a novel and innovative ELISA-based method to quantify the binding efficiencies of our dCas9 fusion proteins: The uniCAS Binding Assay (uniBAss). Biotinylated oligos are coated on 96-well ELISA plates via the interaction with streptavidin and bound dCas9/RNA complexes can be detected via antibodies. We were able to show that this is a powerful tool to characterize the modified dCas9 fusion proteins by assessing their DNA binding capacity with possible improvements for high-throughput screenings. Read more!

  • Manual

    As we believe that our engineered CRISPR/Cas9 system is a promising tool for targeted gene regulation, we would like to offer a manual to the iGEM community for facilitated usage of our toolkit. Therefore we designed an interactive Manual Tool that generates detailed descriptions for your own gene regulation experiments dependent on whether you would like to efficiently repress or activate gene expression. We provide all our experimental knowledge and optimized protocols to everyone who would like to use our uniCAS toolkit. Read more!

  • Application

    Our uniCAS toolkit is a versatile applicable tool. Every expert we talked to had amazing ideas concerning application in their own research!

    “… the use of this toolkit may help us in understanding complex metabolomes, because many enzymes can be regulated at once …” - Prof. Dr. Hess, Genetics of Cyanobacteria

    “... I would use this kit to understand the transcriptional codes of brain development better, by simultaneously regulating various promoters of neural transcription factors ...“ - Dr. Jochen Holzschuh, Neuronal Development

    Read more!

  • Human Practice & Outreach

    In case of safety and ethical issues concerning our project we consulted many biology experts and asked for their opinion and advice. Next we connected synthetic biology with art and music as all the three disciplines require creativity, technical skills and a lot of commitment and also art & music can be used to address a lot of people. We further organized several events to inform about synthetic biology and our project. We went to a political party and schools, participated at an ethical seminar, a science fair and collaborated with other German teams to organize the SynBio Day. Read more!

  • To summarize - In the last months we were able to ...

    • construct a catalytically inactive version of Cas9 (dCas9) and thus generate a DNA binding protein.
    • make our dCas9 accessible to the whole iGEM community by mutating 10 illegal iGEM restriction sites.
    • combine this modified dCas9 with different transcriptional effectors and express them in mammalian cell lines.
    • control mammalian gene expression via our modified CRISPR/Cas9 fusion proteins.
    • build devices for controlling gene expression by different light stimuli.
    • provide an RNA plasmid termed RNAimer for facile insertion of crRNAs which target desired DNA sequences.
    • create an online tool that generates customized manuals for easy usage of our toolkit.
    • develop a method to assess the DNA binding capacity of our dCas9 fusion proteins - the uniBAss.
    • model our system and obtain a possible insight into behavior of measured and unmeasured components, which led us to conclusions how our system could be optimized.
    • truncate dCas9 in order to increase expression rate and express these protein versions.
    • build a cheap and functioning light box, called "uniBOX", for light experiments.

    ... design, develop, test and now offer the universally applicable toolkit "uniCAS" for
    efficient gene regulation to the synthetic biology community.